Davol is a subsidiary of C. R. Bard, one of the leading multinational developers, manufacturers and marketers of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology and surgical specialty products. C. R. Bard markets its products and services throughout the world to hospitals, individual health care professionals, extended care facilities and alternate site facilities. Davol focuses its business on innovative products in key surgical specialties, including hernia repair, hemostasis, orthopaedics and laparoscopy. Its avitene ultrafoam collagen sponge provides surgeons with high quality, cost-effective methods of controlling bleeding intraoperatively, reducing blood loss and minimizing postoperative complications. Davol is headquartered in Cranston, R.I.